American Shared Hospital Services (AMS)
NYSEAMERICAN: AMS · IEX Real-Time Price · USD
3.130
-0.075 (-2.34%)
Jul 2, 2024, 4:00 PM EDT - Market closed

Company Description

American Shared Hospital Services provides stereotactic radiosurgery and advanced radiation therapy equipment.

It operates in two segments, Medical Equipment Leasing, and Retail. The company offers radiosurgery equipment for the Gamma Knife stereotactic radiosurgery, a non-invasive procedure to treat malignant and benign brain tumors, and arteriovenous malformations, as well as for trigeminal neuralgia.

It also provides financing services for Leksell Gamma Knife units; and leases medical equipment. In addition, the company offers proton beam radiation therapy services in Orlando, Florida and Long Beach, California, as well as offers planning, installation, reimbursement, and marketing support services to its customers.

The company markets its solutions to cancer treatment centers, hospitals, and cancer networks worldwide.

American Shared Hospital Services was founded in 1980 and is based in San Francisco, California.

American Shared Hospital Services
American Shared Hospital Services logo
Country United States
Founded 1980
Industry Medical Care Facilities
Sector Healthcare
Employees 31
CEO Raymond C. Stachowiak

Contact Details

Address:
601 Montgomery Street, Suite 1112
San Francisco, California 94111
United States
Phone 415-788-5300
Website ashs.com

Stock Details

Ticker Symbol AMS
Exchange NYSEAMERICAN
Fiscal Year January - December
Reporting Currency USD
CIK Code 0000744825
CUSIP Number 029595105
ISIN Number US0295951059
Employer ID 94-2918118
SIC Code 8071

Key Executives

Name Position
Peter Gaccione Chief Executive Officer
Raymond C. Stachowiak Executive Chairman
Craig K. Tagawa President and Assistant Secretary
Robert L. Hiatt Chief Financial Officer
Alexis N. Wallace CPA Chief Accounting Officer and Corporate Secretary
Ranjit Pradhan Head of Marketing and Customer Advocacy

Latest SEC Filings

Date Type Title
Jul 2, 2024 8-K Current Report
May 15, 2024 10-Q Quarterly Report
May 14, 2024 8-K Current Report
May 13, 2024 8-K Current Report
Apr 29, 2024 ARS Filing
Apr 29, 2024 DEFA14A Additional definitive proxy soliciting materials and Rule 14(a)(12) material
Apr 29, 2024 DEF 14A Other definitive proxy statements
Apr 18, 2024 8-K Current Report
Apr 3, 2024 SC 13D/A [Amend] General statement of acquisition of beneficial ownership
Apr 1, 2024 10-K Annual Report